Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors
Fausto Petrelli, Antonio Ghidini, Maria Chiara Parati, Mara Ghilardi, Karen Borgonovo, Lorenzo Dottorini
Springer Nature ·
2026-11-01
· DOI 10.1007/s10549-026-08132-y
The publisher did not provide an abstract — full text is available via the link below.
Fausto Petrelli, Antonio Ghidini, Maria Chiara Parati, Mara Ghilardi, Karen Borgonovo, Lorenzo Dottorini. Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors. // Breast Cancer Research and Treatment. – 2026. – DOI: 10.1007/s10549-026-08132-y. – URL: https://doi.org/10.1007/s10549-026-08132-y
Fausto Petrelli, Antonio Ghidini, Maria Chiara Parati, Mara Ghilardi, Karen Borgonovo, & Lorenzo Dottorini (2026). Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08132-y
Fausto Petrelli, et al. “Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.” Breast Cancer Research and Treatment, 2026. doi:10.1007/s10549-026-08132-y.
@article{Petrelli2026,
title = {Rechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors},
author = {Petrelli, Fausto and Ghidini, Antonio and Parati, Maria Chiara and Ghilardi, Mara and Borgonovo, Karen and Dottorini, Lorenzo},
journal = {Breast Cancer Research and Treatment},
year = {2026},
doi = {10.1007/s10549-026-08132-y},
url = {https://doi.org/10.1007/s10549-026-08132-y}
}